Lyndsay J . Willmott, MD

Department

Obstetrics & Gynecology (Phoenix)

Position

Assistant Professor

Publications

• Gynecologic oncology
  Powell Matthew, Overall survival among patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial
  190, p. S4 - S5 2024
• Journal of clinical oncology
  Santin Alessandro D, Efficacy and Safety of Sacituzumab Govitecan in Patients With Advanced Solid Tumors (TROPiCS-03): Analysis in Patients With Advanced Endometrial Cancer, p. JCO2302767 2024
• Journal of clinical oncology
  Lokich Elizabeth, Time course of adverse events in primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN-6-NSGO/GOG-3031/RUBY trial
  42:16_suppl, p. 5607 - 5607 2024
• Clinical cancer research
  Lorentzen Georgia M, Cervicovaginal metabolome and tumor characteristics for endometrial cancer detection and risk stratification 2024
• Therapeutic advances in medical oncology
  Auranen Annika, Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
  16, p. 17588359241277656 - 2024
• Journal of minimally invasive gynecology
  Stewart Chelsea, Factors associated with inpatient narcotic medication usage after robotic assisted laparoscopy 2023
• Journal of geriatric oncology
  Moore Madison S., Robotic-assisted gynecologic surgery in an older population: A comparison study
  14:6, p. 101533 - 101533 2023
• International journal of gynecological cancer
  Oaknin Ana, 2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246)
  32:Suppl 2, p. A472 - A472 2022
• International journal of gynecological cancer
  Chase D M, 961 Impact of disease progression on health-related quality of life of advanced ovarian cancer (AOC) patients – pooled analysis from the PRIMA trial
  31:Suppl 3, p. A284 - A284 2021
• Gynecologic oncology
  Eakin C., Cervical Cancer Screening in Pregnancy: Identifying Characteristics of Poor Postpartum Follow-up
  156:3, p. e36 - e36 2020
• Gynecologic oncology
  Moreno A., Factors Associated with Increased Narcotic Usage after Undergoing Robotic Assisted Laparoscopy
  147:1, p. 203 - 203 2017
• Gynecologic oncology
  Barnes Dominique, Patient characteristics associated with obesity in an endometrial cancer patient: first steps towards the design of a weight loss intervention
  147:1, p. 215 - 215 2017
• Gynecologic oncology
  Barnes Dominique, Clinic-based Depression Screening in Gynecologic Oncology Patients using the Patient Health Questionnaires-2 (PHQ-2): are we identifying the highest risk patients?
  147:1, p. 215 - 215 2017
• Gynecologic oncology
  Vo E.H., Robotic-assisted Gynecologic Surgery in an Elderly Population: A Comparison Study
  147:1, p. 204 - 205 2017
• Journal of clinical oncology
  Love Neil, The morbidity and mortality conference (MMC) concept applied to contemporary oncology practice: Retrospective findings on management of 233 patients (pts) who died of ovarian cancer (OC), colorectal cancer (CRC), and wild-type (no identified targetable mu
  35:8_suppl, p. 241 - 241 2017
• Gynecologic oncology research and practice
  Minion Lindsey E., Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study
  3:1, p. 4 - 4 2016
• Journal of gynecologic surgery
  Shields Kristin M., Ten-Year Food and Drug Administration Reporting on Robotic Complications in Gynecologic Surgery
  31:6, p. 331 - 335 2015
• Gynecologic oncology
  Shields K.M., Factors associated with low educational background in uterine cancer patients
  137, p. 123 - 123 2015
• Gynecologic oncology
  Craig C., The characteristics and associations of pelvic pain in gynecologic cancer patients: A single institution study
  131:1, p. 264 - 264 2013
• Angiogenesis (London)
  Trapp Valerie, Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture
  13:4, p. 305 - 315 2010
• Cancer research (Chicago, Ill.)
  Willmott Lyndsay J., Abstract 1399: The effect of radiation therapy with adjunctive oxaliplatin versus cisplatin chemotherapy in cervical cancer cell lines
  70:8_Supplement, p. 1399 - 1399 2010
• Gynecologic oncology
  Monk Bradley J., Anti-angiogenesis agents in metastatic or recurrent cervical cancer
  116:2, p. 181 - 186 2010
• Journal of the National Comprehensive Cancer Network
  Willmott L. J., Biologics in Cervical Cancer Therapy
  8:12, p. 1417 - 1423 2010
• Journal of oncology
  Willmott Lyndsay J., Targeted Therapy in Ovarian Cancer
  2010, p. 740472 - 9 2010
• Expert review of anticancer therapy
  Willmott Lyndsay J, Cervical cancer therapy: current, future and anti-angiogensis targeted treatment
  9:7, p. 895 - 903 2009